Recursion Pharmaceuticals (RXRX) Change in Intangibles (2020 - 2026)

Recursion Pharmaceuticals has reported Change in Intangibles for 6 years, with the latest figure at $80000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Intangibles changed N/A year-over-year to $80000.0; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 33.19% YoY), and the FY2025 full-year result was $2.2 million, down 35.58% from the prior year.
• Change in Intangibles for Q1 2026 stood at $80000.0, down from $2.2 million in the prior quarter.
• The five-year high for Change in Intangibles was $3.0 million in Q2 2024, with the low at $80000.0 in Q1 2026.
• Historically, Change in Intangibles has averaged $810625.0 across 5 years, with a median of $325000.0 in 2022.
• Annual changes were most pronounced in 2023 — Change in Intangibles slumped 72.67% — and 2024, when it changed 0.0%.
• Recursion Pharmaceuticals' Change in Intangibles stood at $300000.0 in 2022, then rose by 16.67% to $350000.0 in 2023, then changed by 0.0% to $350000.0 in 2024, then surged by 516.57% to $2.2 million in 2025, then tumbled by 96.29% to $80000.0 in 2026.
• The last three Change in Intangibles figures came in at $80000.0 (Q1 2026), $2.2 million (Q2 2025), and $350000.0 (Q4 2024), per Business Quant data.